120 related articles for article (PubMed ID: 22126554)
21. Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis.
Shigyo H; Nonaka S; Katada A; Bandoh N; Ogino T; Katayama A; Takahara M; Hayashi T; Harabuchi Y
Acta Otolaryngol; 2007 Sep; 127(9):970-9. PubMed ID: 17712678
[TBL] [Abstract][Full Text] [Related]
22. Prognostic importance of surgical margins in advanced laryngeal squamous carcinoma.
Bradford CR; Wolf GT; Fisher SG; McClatchey KD
Head Neck; 1996; 18(1):11-6. PubMed ID: 8774917
[TBL] [Abstract][Full Text] [Related]
23. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of Bcl-2 and p53 expression in advanced laryngeal squamous cell carcinoma.
Friedman M; Lim JW; Manders E; Schaffner AD; Kirshenbaum GL; Tanyeri HM; Caldarelli DD; Coon JS
Head Neck; 2001 Apr; 23(4):280-5. PubMed ID: 11400228
[TBL] [Abstract][Full Text] [Related]
25. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
26. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
[TBL] [Abstract][Full Text] [Related]
27. Decreasing expression of glucose-regulated protein GRP78/BiP as a significant prognostic predictor in patients with advanced laryngeal squamous cell carcinoma.
Kaira K; Toyoda M; Shimizu A; Imai H; Sakakura K; Nikkuni O; Suzuki M; Iijima M; Asao T; Chikamatsu K
Head Neck; 2016 Oct; 38(10):1539-44. PubMed ID: 27312568
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors in larynx cancers].
Vuralkan E; Akin I; Kuran G; Saka C; Akçayöz N; Alicura S
Kulak Burun Bogaz Ihtis Derg; 2008; 18(4):221-6. PubMed ID: 19052489
[TBL] [Abstract][Full Text] [Related]
29. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
30. Outcome of transoral laser microsurgery for T2-T3 tumors growing in the laryngeal anterior commissure.
Blanch JL; Vilaseca I; Caballero M; Moragas M; Berenguer J; Bernal-Sprekelsen M
Head Neck; 2011 Sep; 33(9):1252-9. PubMed ID: 21837693
[TBL] [Abstract][Full Text] [Related]
31. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
Pizem J; Cör A; Gale N
Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
[TBL] [Abstract][Full Text] [Related]
32. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.
Osman I; Sherman E; Singh B; Venkatraman E; Zelefsky M; Bosl G; Scher H; Shah J; Shaha A; Kraus D; Cordon-Cardo C; Pfister DG
J Clin Oncol; 2002 Jul; 20(13):2980-7. PubMed ID: 12089228
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between the prognosis and the expression of survivin in surgical margins of laryngeal squamous cell carcinoma].
Zhao H; Chen Q; Ren J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jun; 19(12):538-40. PubMed ID: 16176004
[TBL] [Abstract][Full Text] [Related]
34. LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma.
Qiu X; You Y; Huang J; Wang X; Zhu H; Wang Z
Int J Clin Exp Pathol; 2015; 8(5):5519-27. PubMed ID: 26191259
[TBL] [Abstract][Full Text] [Related]
35. The importance of cathepsin's-D tissular detection in laryngeal squamous cell carcinoma.
Lentari I; Segas I; Kandiloros D
Acta Otorhinolaryngol Belg; 2002; 56(4):383-9. PubMed ID: 12528259
[TBL] [Abstract][Full Text] [Related]
36. [Relative factors analysis including carcinoma marker, molecular margin and clinical factors on laryngeal carcinoma recurrence].
Yi H; Zhang B; Liu P; Ni F; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jun; 22(12):529-31. PubMed ID: 18800676
[TBL] [Abstract][Full Text] [Related]
37. [The status of protein P16 and P53 in the surgical margins of laryngeal carcinoma and the association with local recurrence].
Wei B; Tang P; Tu G
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):461-3. PubMed ID: 12768762
[TBL] [Abstract][Full Text] [Related]
38. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
39. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
40. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]